Cubist Is Latest Heptares Collaborator On GPCR-Targeted Drugs

U.S. acute hospital care specialist Cubist has become the sixth major pharma company to collaborate with U.K.-based Heptares on finding novel therapeutics that interact with G-protein coupled receptors.